471 results on '"Walldius, Göran"'
Search Results
52. Thyroid cancer risk in the Swedish AMORIS study : the role of inflammatory biomarkers in serum.
53. Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels - The AMORIS study
54. Antioxidants and atherosclerosis progression: unresolved questions
55. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
56. Probucol and nicotinic acid: old drugs, new findings and new derivatives
57. Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort
58. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
59. Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels – The AMORIS study
60. Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS study
61. Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum
62. Associations between prediagnostic blood glucose levels, diabetes, and glioma.
63. Serum biomarkers to predict risk of testicular and penile cancer in AMORIS
64. Serum inflammatory markers and colorectal cancer risk and survival
65. Fatty acid turnover in the ischaemic compared to the non-ischaemic human heart
66. Effects of Hypolipidemic Regimes on Serum Lipoproteins
67. Impaired Fatty Acid Incorporation Into Adipose Tissue (Fiat) in Hypertriglyceridemia. Effect of Intravenous Fat Infusion on Fiat
68. Effects of Nicotinic Acid and its Derivatives on Lipid Metabolism and Other Metabolic Factors Related to Atherosclerosis
69. Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival
70. Serum and Tissue Lipid Metabolism and Effect of Nicotinic Acid in Different Types of Hyperlipidemia
71. Serum inflammatory markers and colorectal cancer risk and survival.
72. Serum biomarkers to predict risk of testicular and penile cancer in AMORIS
73. Associations between prediagnostic blood glucose levels, diabetes, and glioma
74. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort
75. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
76. Cohort Profile: The AMORIS cohort
77. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients : a competing risk analysis
78. Serum Calcium and the Risk of Breast Cancer : Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies
79. Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
80. Serum lactate dehydrogenase and survival following cancer diagnosis.
81. Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies
82. Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival
83. Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
84. Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden
85. Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden
86. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis
87. Chronic kidney disease and 10-year risk of cardiovascular death
88. Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS study.
89. The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk
90. Fructosamine Is a Useful Indicator of Hyperglycaemia and Glucose Control in Clinical and Epidemiological Studies – Cross-Sectional and Longitudinal Experience from the AMORIS Cohort
91. Serum Glucose and Lipids in Relation to Gastrointestinal Cancer Risk
92. The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study
93. Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study
94. Biomarker-based score to predict mortality in persons aged 50 years and older : a new approach in the Swedish AMORIS study
95. Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study
96. Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons : the Swedish AMORIS study
97. Association between levels of C-reactive protein and leukocytes and cancer : three repeated measurements in the Swedish AMORIS study
98. Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study
99. Serum Calcium and Risk of Gastrointestinal Cancer
100. Country of birth-specific and gender differences in prevalence of diabetes in Sweden
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.